Access
To read this story in full you will need to login or make a payment (see right).
news feature
Nature 410, 624 (5 April 2001) |
A tortured tale of supply and demand
Joanna Downer
Given the breadth of their potential, one might expect that human embryonic stem (ES) cells would be the focus of attention for hundreds of research groups. But so far, only a dozen or so teams have entered the field.
To read this story in full you will need to login or make a payment (see right).